Terms: = Liver cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
173 results:
1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract] [Full Text] [Related]
2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
3. Optimizing lifestyle profiles is potential for preventing nonalcoholic fatty liver disease and enhancing its survival.
Tu B; Li W; Xiao H; Xu X; Zhang Y
Sci Rep; 2024 Mar; 14(1):5516. PubMed ID: 38448563
[TBL] [Abstract] [Full Text] [Related]
4. Injury to the Muscle Layer and Risk of Non-cardiac Chest Pain after Endoscopic Submucosal Dissection for Esophageal cancer.
Tahara T; Shijimaya T; Nishimon S; Kobayashi S; Matsumoto Y; Nakamura N; Okazaki T; Takahashi Y; Tomiyama T; Honzawa Y; Fukata N; Fukui T; Naganuma M
J Gastrointestin Liver Dis; 2024 Mar; 33(1):25-29. PubMed ID: 38386890
[TBL] [Abstract] [Full Text] [Related]
5. Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Chiu LC; Hsu PC; Wang CC; Ko HW; Kuo SC; Ju JS; Tung PH; Huang AC; Yang CT
Thorac Cancer; 2024 Mar; 15(7):529-537. PubMed ID: 38279515
[TBL] [Abstract] [Full Text] [Related]
6. The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral centre in Italy.
Ferronato M; Lalanne C; Quarneti C; Panico ML; Guidi M; Lenzi M; Muratori L
Liver Int; 2024 Mar; 44(3):791-798. PubMed ID: 38230826
[TBL] [Abstract] [Full Text] [Related]
7. Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis.
Patil N; Sahai P; Rastogi A; Sharma N; Shasthry SM; Mukund A; Laroia ST; Kumar G; Pamecha V; Sarin SK
Indian J Pathol Microbiol; 2023; 66(4):744-750. PubMed ID: 38084526
[TBL] [Abstract] [Full Text] [Related]
8. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.
Tai J; Hsu CW; Chen WT; Yang SS; Chiu CH; Chien RN; Chang ML
Cancer Sci; 2024 Feb; 115(2):564-574. PubMed ID: 38083881
[TBL] [Abstract] [Full Text] [Related]
9. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets.
Shi Y; Dong H; Sun S; Wu X; Fang J; Zhao J; Han J; Li Z; Wu H; Liu L; Wu W; Tian Y; Yuan G; Fan X; Xu C
Clin Mol Hepatol; 2024 Jan; 30(1):80-97. PubMed ID: 38061333
[TBL] [Abstract] [Full Text] [Related]
10. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
F1000Res; 2023; 12():417. PubMed ID: 37954063
[No Abstract] [Full Text] [Related]
11. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
[TBL] [Abstract] [Full Text] [Related]
12. Impact of the Prolonged Intermittent Pringle Maneuver on Post-Hepatectomy liver Failure: Comparison of Open and Laparoscopic Approaches.
Doi S; Yasuda S; Hokuto D; Kamitani N; Matsuo Y; Sakata T; Nishiwada S; Nagai M; Nakamura K; Terai T; Kohara Y; Sho M
World J Surg; 2023 Dec; 47(12):3328-3337. PubMed ID: 37787778
[TBL] [Abstract] [Full Text] [Related]
13. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
14. Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal liver Metastases.
Verheij FS; Kuhlmann KFD; Silliman DR; Soares KC; Kingham TP; Balachandran VP; Drebin JA; Wei AC; Jarnagin WR; Cercek A; Kok NFM; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2023 Dec; 30(13):7950-7959. PubMed ID: 37639032
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Mutation Profiling of Colorectal cancer Patients With Lung or liver Metastasis by Targeted Next-Generation Sequencing.
Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
[TBL] [Abstract] [Full Text] [Related]
17. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract] [Full Text] [Related]
18. Gradient-based Volumetric PET Parameters on Immediate Pre-ablation FDG-PET Predict Local Tumor Progression in Patients with Colorectal liver Metastasis Treated by Microwave Ablation.
Zirakchian Zadeh M; Yeh R; Kirov AS; Kunin HS; Gönen M; Sotirchos VS; Soares KS; Sofocleous CT
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):911-920. PubMed ID: 37268735
[TBL] [Abstract] [Full Text] [Related]
19. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
[TBL] [Abstract] [Full Text] [Related]
20. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
[TBL] [Abstract] [Full Text] [Related]
[Next]
